Options: Show MedDRA Preferred Terms, display only 20 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arrhythmia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||||||||
| Asthma | x | x | x | x | x | ||||||||||||||||||||||||||
| Atrial fibrillation and flutter | x | x | x | x | x | ||||||||||||||||||||||||||
| Drug interaction | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||||||||||
| Hyperkinesia | x | x | x | x | |||||||||||||||||||||||||||
| Pulmonary fibrosis | x | x | x | x | |||||||||||||||||||||||||||
| Recurrent ventricular fibrillation | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||||||||
| Respiratory failure | x | x | x | x | |||||||||||||||||||||||||||
| Sinoatrial node dysfunction | x | x | x | x | |||||||||||||||||||||||||||
| Sudden death | x | x | x | x | x | x | |||||||||||||||||||||||||
| Tachyarrhythmia | x | x | x | x | x | ||||||||||||||||||||||||||
| Ventricular arrhythmia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
| Ventricular fibrillation | x | x | x | x | x | x | x | x | x | x | x | ||||||||||||||||||||
| Ventricular tachycardia | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Wolff-Parkinson-White syndrome | x | x | x | x | x | ||||||||||||||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |